Investigation Overview
July 20, 2015 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Alnylam Pharmaceuticals. The investigation by a law firm concerns whether certain Alnylam Pharmaceuticals officers and director...
You must register (for free) or login to view the entire investigation.